MARKET

VTRS

VTRS

Viatris Inc Ord Shs
NASDAQ
14.68
+0.67
+4.78%
After Hours: 14.68 0 0.00% 16:47 04/17 EDT
OPEN
14.06
PREV CLOSE
14.01
HIGH
14.74
LOW
14.06
VOLUME
11.77M
TURNOVER
--
52 WEEK HIGH
16.33
52 WEEK LOW
7.01
MARKET CAP
17.09B
P/E (TTM)
-4.8894
1D
5D
1M
3M
1Y
5Y
1D
QSM Asset Management Loads Up 611,000 Mobileye Shares
The Motley Fool · 18h ago
The 10 Healthcare stocks with the lowest forward P/E ratios
Seeking Alpha · 1d ago
FDA Takes Step Forward on Testosterone Therapy for Men
Benzinga · 1d ago
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga · 2d ago
Viatris Ophthalmology Data At ASCRS Puts Valuation And Dividend In Focus
Simply Wall St · 2d ago
Quant check on David Einhorn's Greenlight Capital holdings post Q1
Seeking Alpha · 3d ago
Teva must face Mylan lawsuit over generic competition for Copaxone
Reuters · 4d ago
Viatris to report first-quarter results, host webcast call
PUBT · 4d ago
More
About VTRS
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.

Webull offers Viatris Inc stock information, including NASDAQ: VTRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTRS stock methods without spending real money on the virtual paper trading platform.